Maxcyte Share Discussion Threads

[assagai] 05/12/2020 21:12

Hi nimbo, reckon it will appear down.....but only because of the UT trade on Fridays close.
I won't be buying any more but only because I'm fully loaded!!
It's my biggest holding now.

Thanks Homebrew

[nimbo1] 05/12/2020 21:01

Hi assagi, not sure how many know the link or appreciate it but if it opens flat or down on Monday I’ll probably pick up some more :)

[nimbo1] 05/12/2020 18:38

hxxps://www.globenewswire.com/news-release/2020/12/05/2140152/0/en/CRISPR-Therapeutics-and-Vertex-Present-New-Data-for-Investigational-CRISPR-Cas9-Gene-Editing-Therapy-CTX001-at-American-Society-of-Hematology-Annual-Meeting-and-Exposition-Together.html

Good news for maxcyte

[homebrewruss] 02/12/2020 23:32

Good twitter thread on MXCT

[bamboo2] 02/12/2020 09:23

No online quote to buy at the moment.

[bamboo2] 02/12/2020 09:13

The 'no-reason' breakaway gap at 370-374 is probably going to fill.
This gap was the result of a tip somewhere I think.

It is an area of historical support and will hold imo.
Possible turn shows on the chart 2-3/12/2020

[assagai] 02/12/2020 08:37

Always a slight concern, when one of your holdings seems to tumble on nothing known in the market......

[acuere] 23/11/2020 11:52

Encouraging progress.

[rgmgo] 18/11/2020 08:28

There was a CARMA Q&A entitled, "MCY-M11, a CAR-PBMC cell product transiently expressing a mesothelin targeted mRNA CAR during SITC's Poster Symposium with a live Q&A on Thursday, November 12. I haven't seen a transcript of this. The Stifel presentation slides (17th Nov) have now been posted on the MXCT Investor site. I note a slight change in the wording on a CARMA deal ''Management exploring independent investment to drive the CARMA opportunity, following recent positive progress, targeting to be self funded by end of 2020''. Targeting would have been better wording to use from the start, these deals are complex. ''Positive progress'' is good &, in any event IMO, some slippage in timing, as long as not excessive, doesn't change the equity story. To be noted though.

[assagai] 13/11/2020 14:19

Edward , what presentation? I didn't think it was until 17th and then 19th?
Thanks, if you can explain.

[nimbo1] 13/11/2020 14:18

not yet but I hope to when they appear on the website.

Sounds exciting and importantly sounds like something the Americans should value!

[edwardt] 13/11/2020 13:59

anyone else listen in ? presentation done as Carma not maxcyte so underlined the split is likely. got to hope external funding is soon.the fact that it mentioned effective and long term antitumour immune responses has to be bloody exciting doesn't it?!

[nimbo1] 11/11/2020 15:36

Interesting, thanks for flagging - $1 billion market cap! Company has been around many years but maxcyte has a c.90% market share I believe in their niche...so whatever they are doing it doesn't appear to be competing well. However in time I would expect some form of proper competition to maxcyte as the market looks attractive!

[rgmgo] 11/11/2020 11:57

I share the warm feelings towards the MXCT investment proposition outlined by the majority on this site but it is clearly worth keeping an eye on competitive
developments. MXCT has enormous advantages as a technology pioneer, and from deep customer relationships, and assuming the industry successfully scales there will probably be space for Precigen (see press release below) and others. For general interest.
hxxps://investors.precigen.com/news-releases/news-release-details/precigens-ultraporatortm-receives-fda-clearance-manufacturing

[assagai] 11/11/2020 09:12

Looking in depth at these with their future planned moves their valuation seems significantly at odds compared to their peers. I don't really hold with posters talking about holdings in detail but I will admit to shifting quite a bit around in ISA and Sipp such that MXCT is my largest holding now and I look upon it as the route to a comfortable retirement!🥱

Who knows as a cash generator, maybe even divis one day..

[adamb1978] 11/11/2020 08:54

Thanks. Website is a lot better. Agree that the next 12 months should hopefully be very rewarding in these, though planning to hold much longer than that!

[nimbo1] 11/11/2020 07:09

Hope so - they appear to be getting ready for the next 12 months really. Team appointment, new website etc - spin off should be 2020 as far as we know and nasdaq float next year. Not sure about the next few weeks but Im hoping for a good next 12 months!

[assagai] 11/11/2020 06:56

Thanks Nimbo, more good times ahead fairly soon, we think?

[nimbo1] 11/11/2020 06:29

hxxps://maxcyte.com/

Nice new website with good info

[tomps2] 06/11/2020 10:38

MXCT mentioned very briefly at 42m54s by Paul Jourdan, in his piworld interview yesterday.

Great insight to where he's looking for future winners, and how he views the small cap space.

Video:

Podcast:

[acuere] 05/11/2020 14:18

Interesting trades and share price movement this week. 800k at 400p reported today. If it’s a delayed sell that explains the drop and bounce back. Or was it a delayed buy the MMS accommodated?
Also the old classic 1 share trade signal at 8.17 seemed to trigger today’s rise.